Worth reading
47Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Conditional
How definitive the wording is.Announced details
Perfusio
Applicable field (uses covered by this announcement)
Drug delivery to body parts and organs where blood flow can be temporarily isolated, including the upper and lower limbs, kidneys, bladder and uterus
Launch dateFY2027 (target start of manufacturing and sales)
Award/certification name
Trademark registration (Perfusio)
Registration number and expiry date
Trademark Registration No. 70800185 (expiry date: Not disclosed)
In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.
| Item | Details |
|---|---|
| Names of Products / Services Covered | Perfusio |
| Launch date | FY2027 (target start of manufacturing and sales) |
| Applicable area | Drug delivery to body parts and organs where blood flow can be temporarily isolated, including the upper and lower limbs, kidneys, bladder and uterus |
| Award/certification name | Trademark registration (Perfusio) |
| Registration number and expiry date | Trademark Registration No. 70800185 (expiry date: Not disclosed) |
Items this document does not state (13)
CounterpartyCounterparty overviewRelationship with the CompanyContract ValueOffering priceContract DateAwarding / certifying bodyLocationLocation scaleQuantitative EffectsUsage historyImpact on Business PerformanceSource
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To protect the “Perfusio” brand and advance its commercialization.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.